MK-1200

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-1200, covering 2026-03-06 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Results: Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) [Phase 1, Phase 2]